C21 Investments Inc.
CWLXF- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0000831609
No open-market purchases or sales by C21 Investments Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of CWLXF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of C21 Investments Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of C21 Investments Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on C21 Investments Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 202510:26 AM ET | Nomura Holdings Incand 1 other | 13G/A | 4.20%5.07M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 2024 | Nomura Holdings Inc | 13GOld format | – | New | – | SEC |
| Feb 2, 2024 | Cowen Financial Products LLC | 13G/AOld format | – | – | – | SEC |
| Jan 23, 2023 | Cowen Financial Products LLC | 13G/AOld format | – | – | – | SEC |
| Jan 20, 2022 | Cowen Financial Products LLC | 13G/AOld format | – | – | – | SEC |
| Jan 19, 2022 | Cowen Financial Products LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Cowen Financial Products LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell C21 Investments Inc. shares.
No Form 144 notices for C21 Investments Inc. are on file.